Live feed
Filing
SC 13D/A
SC 13D/A0001104659-17-057375·CRISPR Therapeutics AG
Schedule 13D ownership disclosure
PHASERX, INC.
Security class unavailable · CUSIP: 71723F103
Event date: 2017-09-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,736,032
- Percent of class
- 6.7400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-057375
- Form type
- SC 13D/A
- Filer
- CRISPR Therapeutics AG
- CIK
- CIK 1674416
- Filed
- Sep 15, 2017
- Reporting period
- Sep 05, 2017
- Description
- Schedule 13D beneficial ownership